Oxford BioMedica Agrees To Acquire GMP Manufacturing Facility

(RTTNews) – Oxford BioMedica PLC (OXB.L: News ) said it agreed to buy a manufacturing facility based in UK from RecipharmCobra Biologics, the biologics division of Recipharm AB, for a purchase price of £1.9 million.

The acquisition and operation of the manufacturing facility is a planned use of proceeds following the company’s recent £20 million fundraising which closed on 10 January 2011. The acquisition of the facility is anticipated to be completed by the end of February 2011.

In addition, the acquisition will also reduce the company’s dependence on a single manufacturing source for its growing clinical portfolio and facilitate the rapid implementation of improved manufacturing processes at increased scale.

Click here to receive FREE breaking news email alerts for Oxford BioMedica and others in your portfolio


Josh Sandberg

Josh Sandberg is the President of Ortho Spine Partners and Partner for The De Angelis Group. He also serves as Co-Founder and Editor of OrthoSpineNews.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Themed By Curio Display Cabinets